| Form of release | Blister (25 tablets), Pack (100 tablets) |
|---|---|
| International Name | S-23 |
| Chemical Name | (2S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro-4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide |
| Type of Drug Combination | SARM (selective androgen receptor modulator) |
| Molecular Formula | C18H13ClF4N2O3 |
| Molecular Weight | 416.76 g/mol |
| Halflife | Around 12 hours, Around 12 hours |
| Mechanism of Action | Selectively binds to androgen receptors, stimulating muscle growth and bone density, while partially suppressing endogenous testosterone production. |
| Anabolic Activity | Very high |
| Androgenic Activity | Average |
| Main Effects | Increased muscle mass and strength, improved muscle density, accelerated fat burning, increased libido, improved recovery |
| Side Effects | Suppression of testosterone, decreased sperm production, possible increase in aggression, insomnia, sweating, headaches, irritability |
| thenecessityofpct | Required, Required |
| Recommended Dosage | 10–30 mg per day |
| Course Duration | 6–8 weeks |
| Reception Hours | In the morning and before training |
| Impact on Estrogens | No |
| Impact on the Liver | Moderate |
| Storage | In a dry, cool place, protected from light, at a temperature not exceeding 25°C, In a dry, cool place, protected from light, at a temperature not exceeding 25°C |
| Use by Women | Not recommended due to high risk of virilization |
| Detection Period in the body | Up to 2–4 weeks |
